The case has been described as groundbreaking and likely to shape the landscape of pharmaceutical litigation for years to come.
Following her husband’s death, the plaintiff, Wendy Dolin, started a non-profit organization called MISSD (Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin) in order to raise awareness concerning a medication-induced side effect called akathisia, a phenomenon marked by extreme internal restlessness and mental disturbance long linked with the induction of suicidal and homicidal behavior.
Baum Hedlund continues to accept and investigate Paxil and generic paroxetine suicide cases on behalf of families whose loved ones have taken their own lives while on Paxil or generic paroxetine and patients who have attempted suicide while taking Paxil or generic paroxetine.
Wisner’s Publication of Documents Described as ‘The Monsanto Papers’ Make Headlines
Wisner also made headlines last summer when he posted internal Monsanto documents on the Baum, Hedlund, Aristei & Goldman website. The documents were then widely used in published articles by journalists from around the world, including the New York Times.
The discovery documents were posted on Baum Hedlund’s website after Monsanto failed to file a motion to preserve their confidentiality within 30 days of the firm’s challenge to Monsanto’s confidentiality designations. As a result of this failure, confidentiality was terminated by the terms of the Protective Order.
The documents, now a part of ‘The Monsanto Papers,’ suggest Monsanto ghostwrote academic articles exploring, among other things, the health risks associated with Roundup and its active ingredient, glyphosate. “Clearly Monsanto’s lawyers made a mistake,” Wisner told the New York Times after the documents went public.
“They didn’t properly take action to preserve the confidentiality of these documents. Now the world gets to see these documents that would otherwise remain secret.”
Wisner sent the declassified documents to the Environmental Protection Agency’s Office of the Inspector General, European regulators and European parliament which led to important safety investigations in the EU and a widespread inquiry into Monsanto’s scientific manipulations of carcinogenicity data.
Thousands of people from across the country have filed lawsuits against Monsanto alleging exposure to Roundup weed killer caused them to develop non-Hodgkin lymphoma. In addition to the federal multidistrict litigation in San Francisco, individuals from California, Nebraska, Delaware and Missouri have filed claims in state courts making similar allegations.
Baum, Hedlund, Aristei & Goldman is one of the leading firms in the Monsanto Roundup litigation, representing over 700 individuals in state and federal claims. Baum Hedlund also represents individuals in a class action lawsuit against Monsanto for allegedly falsely promoting Roundup products as interfering with an enzyme that is found only in plants, but not “in people or pets,” even though beneficial bacteria in the human gut, mucus membranes and skin depend on the same enzyme that Roundup targets.